Showing results (1981-1990 of 6,668) with videos related to

Sort By:
Pageof 667
Plos One|April 5, 2013
Ex vivo modeling of chemical synergy in prenatal kidney cystogenesisCorina Anders, Nick Ashton, Parisa Ranjzad, et al.
Journal of Neuroscience Methods|April 16, 2013
Antibody testing for brain immunohistochemistry: brain immunolabeling for the cannabinoid CB₂ receptorJean-Ha Baek, Cynthia L Darlington, Paul F Smith, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 12, 2013
Pilot evaluation of a substance abuse prevention group intervention for at-risk bariatric surgery candidatesKathleen Ashton, Leslie Heinberg, Julie Merrell, et al.
Pharmacology & Therapeutics|June 15, 2013
Cardiovascular adenosine receptors: expression, actions and interactionsJohn P Headrick, Kevin J Ashton, Roselyn B Rose'meyer, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 24, 2026
Sweat Output on the Dorsal Aspect of the Forearm and FootGary W Mack, Arianna M Young, Kaylee Bahr, et al.
American Journal of Veterinary Research|March 23, 2026
Fracturoscopy is comparable to fluoroscopy for intraoperative assessment of fracture apposition during indirect reduction of simulated diaphyseal antebrachial fractures in dog cadaversEmma A Devereux, Ashton C Berger, Daniel D Lewis, et al.
Insect Biochemistry and Molecular Biology|September 16, 2014
Peroxinectin catalyzed dityrosine crosslinking in the adhesive underwater silk of a casemaker caddisfly larvae, Hysperophylax occidentalisChing-Shuen Wang, Nicholas N Ashton, Robert B Weiss, et al.
The American Journal of Psychiatry|May 1, 1985
Family interaction patterns among Japanese-American and Caucasian families in HawaiiJ Hsu, W S Tseng, G Ashton, et al.
Neurorehabilitation|May 14, 2026
A Scoping Review Examining Rehabilitation Practice for Individuals Within Disorders of ConsciousnessJenna Neikirk, Ashton Woolum, Cayla Robinson, et al.
Journal of Medical Economics|March 4, 2026
Budget impact model of nadofaragene firadenovec for the treatment of high-risk non-muscle-invasive bladder cancer that is unresponsive to Bacillus Calmette-Guérin immunotherapyMin Yang, Xinglei Chai, Dongni Ye, et al.
Pageof 667